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ABSTRACT 
 
Aims: The objective of this study is to detect the prevalence of qnr genes in broad-spectrum beta-
lactamase producing Klebsiella pneumoniae, involved in hospital and community-acquired 
infections.  
Study Design: It is a retrospective study. 
Place and Duration of Study: Bacteriology and virology laboratorie of Institut Pasteur, Abidjan, 
Côte d'Ivoire. 
Methodology: From January 2011 to June 2016, 350 Klebsiella pneumoniae were isolated from 
various clinical specimens and identified by conventional bacteriological tests. Antibiotic resistance 
(beta-lactams, quinolones and aminoglycosides) and detection of broad-spectrum beta-lactamases 
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were assessed by the diffusion method and the synergy test, respectively. Molecular 
characterization of quinolone resistance genes (qnr A, qnr B and qnr S) was performed by the 
conventional polymerase chain reaction (PCR).  
Results: Of the 350 Klebsiella pneumoniae isolates, 91(26%) were detected as ESBL producer, 
36.2% (n=33) recovered from urine, 24.2% (n=22) from pus and 20.8% (n=19) from blood culture 
respectively. 46(33%) strains were idenifed to carry qnr genes, qnrB predominate 33(71%), 
followed by qnr 12(26.1%) and qnrA 1(2.2%). The strains exhibited high resistance to most of the 
agents tested, expect imipemen, low resistance to amikacin 4.1%, moderate to cefoxitin 31.8% and 
54.9% with amoxicillin-clauvanic acid. 
Conclusion: Although these observed prevalences are small proportions, this can be seen as a 
warning signal for the future. The emergence and dissemination of resistance genes in Côte 
d'Ivoire could pose a public health problem. Thus, the establishment of a relevant resistance 
surveillance policy to better control the circulation of multidrug-resistant strains is necessary. 
 
 
Keywords: Klebsiella pneumonia; genes; resistance; quinolone; beta-lactamase; emergence. 
 
1. INTRODUCTION 
 
Quinolones and fluoroquinolones are molecules 
of choice, used to treat a wide variety of bacterial 
infections in humans [1]. The abusive use of 
these antibiotics has led to the progressive 
emergence of resistant bacteria, causing 
therapeutic failures that represent a real public 
health problem [2]. Support for quinolone 
resistance other than the chromosome was 
described for the first time in Klebsiella 
pneumoniae [3]. In addition, three mechanisms 
of plasmid resistance have recently been 
described. These include the quinolone-specific 
efflux pump [4], the protection of quinolone 
targets by qnr proteins [3] and the hydrolysis of 
quinolones By a protein derived from an enzyme 
responsible for aminoglycoside resistance (AAC 
(6) -1b-cr) [5]. The genetic determinant of this 
resistance is borne by mobile genetic elements 
such as plasmids and transposons. These 
elements allow the dissemination of resistance 
genes through horizontal transfer, resembling the 
genetic engineering methods developed in the 
laboratory [6]. Three types of qnr genes are 
known, qnr A genes with six (06) subtypes, qnr B 
with 19 subtypes and qnr S with three (03) 
subtypes [7]. In the world and particularly in Côte 
d'Ivoire, the resistance of bacteria to quinolones 
and fluoroquinolones has become a real concern 
for healthcare workers as well as for patients, as 
Guessennd and al. [8] and Ouattara and al. [9]. 
However, in Côte d'Ivoire, very little data are 
available on the qnr genes, hence the interest of 
this study whose main objective is to determine 
the prevalence of qnr A, B and S genes in 
Klebsielle pneumoniae producer of beta-
lactamases isolated in patients hospitalized in 
Abidjan (Côte d'Ivoire). 
2. MATERIALS AND METHODS 
 
2.1 Strain Collection 
 
Klebsiella pneumoniae strains isolated from 
various clinical specimens were collected from 
January 2011 to June 2016. The strains were 
isolated by direct inoculation of Drigalski medium 
containing 2 mg / L ceftazidime (homemade 
medium) [10]. The identification of the stains was 
carried out by the gallery of the reduced rack of 
LEMINOR in the laboratory of bacteriology and 
virology of Institut Pasteur of Ivory Coast (IPCI). 
 
2.2 Bacterial Sensitivity 
 
2.2.1 Antibiogramme 
 
Sensitivity to antibiotics was determined by the 
diffusion method of discs in agar medium 
(Müeller-Hinton) according to the 
recommendations of the Antibiogram Committee 
of the French Society of Microbiology [11]. The 
antibiotic discs tested were amikacin (30 µg), 
ciprofloxacin (5 µg), nalidixic acid (30 µg), 
norfloxacin (10 µg), cefotaxime (30 µg), 
ceftazidime), Ceftriaxone (30 µg), aztreonam (30 
µg), cefalotin (30 µg) cefoxitin (30 µg) tobramicin 
(10 µg) and amoxicillin-clavulanic acid (20/10 
µg). 
 
2.2.2 Detection of broad spectrum beta-
lactamase production (ESBL) 
 
The double synergy method was used for the 
detection of Klesbiella pneumoniae ESBL 
according to [12]. This consisted in placing the 
cephalosporin discs of 3rd generation 
(cefotaxime, ceftriaxone and ceftazidime) and 
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aztreonam at 30 mm around a central disc of 
amoxicillin clavulanic acid according to the 
recommendations of the French Committee of 
Antibiogramme of the French Society of 
Microbiology [11]. The presence of ESBL is 
represented by a distortion of the inhibition zone, 
with respect to the disc containing the clavulanic 
acid, thus describing a "champagne stopper" 
image. Only the isolates of Klebsiella 
pneumoniae ESBL which showed resistance to 
aminoglycosides and fluoroquinolones were 
taken into account in this study. 
 
The reference strain E. coli ATCC 25922 was 
included in the course of the antibiograms in 
order to carry out the positive control. 
 
2.3 Genotyping of Strains of Klebsiella 
pneumoniae ESBL 
 
Extraction of the plasmid DNA from the Klebsiella 
pneumoniae strains and the reference strains 
(Table 1) was carried out by the alkaline lysis 
method with phenolyzation (homologous 
protocol). Conventional PCR detected the 
quinolone resistance genes (qnr A, B and S). 
Pairs of specific primers were used to amplify the 
fragments of the genes encoding each resistance 
(Table 2). The PCR amplification was carried out 
in a volume of 50 µl with the thermocycler 
(Perkin® Elmer Gen Amp Lapplied Biosystems 
9700). The PCR amplification conditions used to 
detect qnr, included a pre-denaturation step at 
94°C for 5 min followed by 30 cycles at 94°C for 
30 s, 55°C for 30 s and 72°C For 60 s, with 
polishing at 72°C for 10 minutes. The reaction 
medium is composed of 5 µl of plasmid DNA, 0.3 
U of Taq polymerase (Promega), 10 µM dNTP 
mixture, 10 µM MgCl2, 10 µM each target primer, 
and 5X PCR buffer (final concentration). Another 
DNA-free reaction mixture was used for the 
negative control. The amplified products were 
analyzed by electrophoresis in a 1.5% agarose 
gel (Invitrogen) stained with ethidium bromide. 
The reading was carried out on the ultraviolet 
plate (Gel doc). 
 
3. RESULTS AND DISCUSSION 
 
3.1 Bacterial Strains 
 
Out of a total of 350 strains of Klebsiella 
pneumoniae collected from January 2011 to 
June 2016, 91 were ESBL producers. The 
prevalence observed for these ESBL isolates 
with antibiotics was 26%. The distribution of 
ESBL-producing strains according to clinical 
specimens is shown in Fig. 1. Klebsiella 
pneumoniae is elevated in urine (36.2%), 
followed by pus (24.2%) and blood (20.8%). 
 
3.2 Sensitivity of Strains of Klebsiella 
pneumoniae ESBL 
 
3.2.1 For beta-lactams 
 
The strains tested were all susceptible to 
imipenem (99%) with the exception of one strain. 
Resistance was 31.8% for cefoxitin, 92.3% for 
ceftazidin and cefotaxime, 93.4% for ceftriaxone, 
and 100% for cefalotin. As for aztreonam, the 
level of resistance was 90.1% and finally 54.9% 
for amoxicillin and clavulanic acid. 
 
Table 1. Characteristics of reference strains taken as controls 
 
Bacteria Numbers Characteristics Positive control 
E. coli 
E. coli 
E. coli 
U2A 2118 
U2A 2119 
U2A 2120 
qnrA1 
qnrB1 
qnrS1 
Controls 
Positives genes qnr 
A, B, S 
qnr = Quinolone résistance 
 
Table 2. List of primers to be used for detection 
 
Genes 
 
sequences 5'-3' References Size of the 
amplicon 
(bp) 
qnrA Amorce F TTCTCACGCCAGGATTTGAG Seyed et al. (2014)  Jundishapur 571 
Amorce R TGCCAGGCACAGATCTTGAC J Microbiol. 2014 july;7 (7) e11136 
qnrB Amorce F TGGCGAAAAAATTGAACAGAA Seyed et al. (2014)  Jundishapur 594 
Amorce R GAGC AAC GATCGCCTGGTAG J Microbiol. 2014 july;7 (7) e11136 
qnrS Amorce F GACGTGCT AAC TTGCGTGAT Seyed et al. (2014)  Jundishapur 388 
Amorce R AAC ACCTCGACTTAAGTCTGA J Microbiol. 2014 july;7 (7) e11136 
3.2.2 For floroquinolones 
 
The rate of resistance to quinolones was 67% for 
ciprofloxacin, 50.5% for nalidixic acid and 73.6% 
for norfloxacin. 
 
3.2.3 For aminoglycosides 
 
The resistance of the strains to aminoglycosides 
revealed that only amikacin was the most active 
molecule with only 4.4% resistance. As for 
tobramicin and gentamicin, all strains were 
resistant to 84.6% and 74.7%, respectively.
 
3.3 Search for Qnr Genes 
 
The PCR technique allowed the detection of 46 
strains of the 91 analyzed with the qnr gene, ie a
prevalence of 50.54% with a predominance of 
type B. Thus, on the 46 strains 33, the qnr B 
gene (594 bp) 71.73%, 12 strains possess qnr S 
(388 bp) or 26.08% and a single strain 
possesses qnr A (571 bp), that is to say 2.17%. 
Fig. 2 shows the genes qnr B and S with 
respective positive bands 594 and 388 base 
pairs. 
 
Klebsiella sp are a group of microorganisms 
frequently isolated from biological products 
following a bacterial infection. It has b
reported according to the publications of Bao et 
al. [13] and Rangaiahagari et al. [14] that 
and Klebsiella sp are the most commonly 
encountered species.In this report, 36.2% of 
Klebsiella pneumoniae was isolated from urine. 
This observed isolation predominance was 
 
Fig. 1. Distribution of strains of 
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een 
E. coli 
reported by Hashemi et al. [15] in Iran with 
69.3% and Raji et al. [16] with 64.7% in Nigeria. 
However, high rates of positive blood cultures 
with K. pneumoniae ESBL have been described 
by some authors [17,18]. 
 
The sensitivity of strains of 
pneumoniae is characterized by a high level of 
resistance to antibiotics, namely beta
aminoglycosides and quinolones. Thus, a 
prevalence of 26% of ESBL-producing strains 
and up to 90% resistance to third
cephalosporins has been observed. This 
situation is related to the hospital origin of the 
strains studied. According to several studies, 
antibiotic-resistant Klebsiella pneumoniae
often involved in nosocomial infections [19
 
With respect to the qnr gene data, this study 
detected 46 strains of the 91 analyzed with the 
qnr gene, ie a prevalence of 50.54% with a 
predominance of type B. This frequency is higher 
than that reported by Guessennd et al. [8] in 
Côte d'Ivoire, who reported a preva
14.6% for the qnr B gene that was most frequent, 
9.9% for qnr A and 2.7% for the qnr S gene. 
Ouattara et al. [9] also detected the qnr S gene in 
Côte d’Ivoire in isolates from different 
ecosystems with a very high prevalence of 95% 
in animals. However, the qnr A and qnr B genes 
have not been detected. Studies in China, the 
USA and Slovenia have found low prevalences 
between 0 and 12% [21,22,23]. The prevalence 
rates of the qnr genes observed by these 
different authors are lower than the
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Fig. 2. 1.5% agarose gel electrophoresis showing multiplex PCR for the simultaneous 
detection of the qnr, B and S genes 
Lane M: molecular weight marker (Invitrogen, 100 bp DNA Ladder); Lane CN: Negative control; Lane CB1: 
Positive control qnr B (594 bp); Lane CS2: Positive control qnr S (388 bp); Lane 39, 40, 42 and 44: positive 
samples for qnr B 
 
prevalence obtained in this study. This       
situation is not only a major concern in the 
therapeutic management of patients,          
because the presence of this gene (qnr) is a 
potential risk of horizontal transfer by mobile 
genetic elements (plasmid and transposon) from 
one bacterium to another. It therefore appears 
necessary to put in place measures to monitor 
bacterial resistance to antibiotics in different 
ecosystems of countries. In addition, qnr-positive 
isolates show resistance to aminoglycosides and 
beta-lactams. This may be explained by the fact 
that plasmid support of quinolone resistance is 
associated with integrons bearing resistance 
determinants to several other antibiotics such as 
beta-lactams and aminoglycosides [24]. The 
coexistence of genes of resistance to          
various families of antibiotics in the same 
bacterium can pose a diagnosis and           
therapy problem according to Roh et al. [25]. 
Previous studies have also shown that most 
ESBL genes are located on transposons and                
on self-transferable plasmids, which generally 
co-exist with the plasmid-mediated quinolone 
resistance determinants [26,27]. This phenotype 
could reflect the excessive use of beta-lactam 
and Quinolones and the absence of strict 
antimicrobial policies in health care facilities. 
 
Moreover, the conventional PCR technique used 
in this study has shown limits, although it has 
made it possible to identify the genes qnr A, B 
and S. In fact, the primers used do not make it 
possible to screen all the variants qnr described 
so far. Other quinolone plasmid resistance genes 
have recently been described: qnr C and qnr D 
[28,29]. 
The presence of genes of resistance to 
quinolones and fluoroquinolones at the level of 
strains of human origin raises the question of the 
origin of these strains carrying the qnr genes. 
Would they be strains carried by medical 
personnel or patients from another service? 
Whatever the response to these problems, the 
presence of the qnr gene in hospitals or in the 
community, is a threat of diffusion of 
multiresistant bacteria for which a solution must 
be considered. 
 
4. CONCLUSION 
 
The emergence of mechanisms of quinolone 
plasmid resistance is a real threat to the efficacy 
of fluoroquinolones at several levels. First, their 
presence on conjugative plasmids promotes their 
mobility and their dissemination in the various 
pathogenic bacteria. Moreover, their association 
with other determinants of resistance, contributes 
to a cosmelection of resistance to antibiotics. 
Plasmid mechanisms of quinolone resistance 
independently confer a low level of resistance to 
fluoroquinolones, but their presence could also 
promote evolution towards a higher level of 
resistance by mutation selection in the targets of 
these molecules. The emergence of this 
combination of resistance genes in Côte d'Ivoire 
could pose a public health problem. Hence the 
need for a relevant resistance surveillance policy 
to better control the circulation of multidrug-
resistant strains. Moreover, for future studies of 
other amplification primers (qnr C and qnr D) 
could finally be used to have an overview of the 
qnr genes. Therefore, the sequencing of the qnr 
detected in this study would make it possible to 
  M     CN    CB1    CS2     39      40        41      42        43     44  
500bp 
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know the different variants existing in Côte d 
'Ivoire. 
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